Form 4: Clorox VP Laurene Peck Receives RSU Grant

Clorox VP Laurene Peck acquired 1,441 shares of common stock through a restricted stock unit grant, scheduled for September 16, 2025, and vesting over four years.

Summary

• Laurene E. Peck, VP CAO & Corp Controller of Clorox Co. (CLX), is acquiring 1,441 shares of common stock.
• The acquisition is in the form of Restricted Stock Units (RSUs) at a price of $124.85 per share.
• The transaction date for this acquisition is scheduled for September 16, 2025.
• Following this transaction, Peck will beneficially own 5,821 shares directly and 100 shares indirectly through a Trust of Parent.
• The RSUs will vest in four equal installments, with 1/4 vesting on October 5, 2026, 2027, 2028, and 2029.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The filing reports a routine grant of Restricted Stock Units to a key executive, which is a standard component of compensation and aligns management's interests with long-term shareholder value. It does not contain unexpected positive or negative news.

Positives

• Insider acquisition of shares, indicating management's confidence in the company's future.
• Long-term vesting schedule aligns management's interests with long-term shareholder value.
• Transaction is part of a pre-arranged Rule 10b5-1 plan, demonstrating structured equity compensation.

Future Outlook

The Restricted Stock Units are scheduled to vest in four equal annual installments, beginning October 5, 2026, and concluding October 5, 2029, indicating a long-term incentive structure for the executive.

Industry Context

The grant of Restricted Stock Units is a common form of equity compensation for executives, aligning their financial interests with the long-term performance of the company and shareholder value. This practice is standard across many industries, including consumer goods.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) with a multi-year vesting schedule is a standard practice in executive compensation across publicly traded companies, including peers in the consumer staples sector like Procter & Gamble (PG) or Kimberly-Clark (KMB), which also utilize similar long-term incentive plans to retain talent and align executive interests with shareholder returns. Specific comparable projects or results are not applicable for a Form 4.

Stakeholder Impact

• Shareholders: Positive, as the RSU grant aligns the executive's long-term financial interests with shareholder value creation.
• Employees: May signal stability and a standard approach to executive compensation.

Next Steps

• Vesting of 1/4 of the Restricted Stock Units on October 5, 2026.
• Vesting of 1/4 of the Restricted Stock Units on October 5, 2027.
• Vesting of 1/4 of the Restricted Stock Units on October 5, 2028.
• Vesting of 1/4 of the Restricted Stock Units on October 5, 2029.

Key Dates

Recommendation

This Form 4 reports a routine equity compensation grant to an executive, which is an expected part of their compensation structure. It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily indicates alignment of executive incentives with long-term shareholder interests.

Keywords

Clorox, CLX, Laurene Peck, Form 4, insider transaction, restricted stock units, RSU, equity compensation, Rule 10b5-1, beneficial ownership